Summaries & Highlights
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA
FEATURING
Sara Tolaney,
Hope Rugo
- 10 views
- December 22, 2024
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Precision Medicine in Breast Cancer
FEATURING
Laura van ’t Veer
- 11 views
- December 19, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer
FEATURING
Heather McArthur
- 71 views
- December 19, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3
FEATURING
Adam Brufsky
- 168 views
- December 18, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 155 views
- December 17, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 105 views
- December 17, 2024
- 4
HR+
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 5 views
- December 22, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 88 views
- December 22, 2024
- 6
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PADMA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 64 views
- December 22, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Nab-Paclitaxel vs. Solvent-Based Paclitaxel in High-Risk eBC - Final Survival Results of WSG ADAPT HR+/HER2- Trial
FEATURING
Sherko Kuemmel
- 6 views
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Oncotype DX Risk Stratification on Chemotherapy Use and Survival Outcomes in HR+ Node- eBC
FEATURING
Kai Johnson
- 6 views
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Prediction of Chemotherapy Benefit by MammaPrint® in HR+/HER2- eBC - FLEX Registry Data
FEATURING
Adam Brufsky
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: MammaPrint® and Predictive Pathways of CDK4/6 Inhibitor Resistance in ER+/HER2- eBC
FEATURING
Adam Brufsky
- 2 views
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, and PI3K Pathway on Elacestrant Outcomes in HR+/HER2- Advanced Breast Cancer
FEATURING
Maxwell Lloyd
- 10 views
- December 17, 2024
HER2-Low
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 5 views
- December 22, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Valemetostat + T-DXd in Previously Treated, Unresectable or Metastatic HER2-Low Breast Cancer
FEATURING
Sara Tolaney
- 3 views
- December 17, 2024
HER2+
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: PATINA - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 88 views
- December 22, 2024
- 6
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Effectiveness of Post-T-DXd Treatments in HER2+ mBC - EN-SEMBLE Study
FEATURING
Kazuki Nozawa
- 3 views
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd
FEATURING
Sara Tolaney
- 2 views
- December 17, 2024
Triple-Negative Breast Cancer (TNBC)
No available content for Triple-Negative Breast Cancer (TNBC), yet.
Other Videos
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA
FEATURING
Sara Tolaney,
Hope Rugo
- 10 views
- December 22, 2024
- 2
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EMBER-3 - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 45 views
- December 22, 2024
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Clinically Actionable Genomic Alterations and Prognostic Insights in Breast Cancer Brain Metastases
FEATURING
Gaia Griguolo
- 7 views
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Lobular vs. Ductal Carcinoma Outcomes by Molecular Subtypes in Young Women With eBC Receiving Neoadjuvant Chemo
FEATURING
Jason Jincong Freeman
- 3 views
- December 20, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: William McGuire Memorial Lecture - Advancing Precision Medicine in Breast Cancer
FEATURING
Laura van ’t Veer
- 11 views
- December 19, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer
FEATURING
Heather McArthur
- 71 views
- December 19, 2024
- 3
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Breast Cancer Polygenic Risk Score and Patient Survival Outcomes in Pathways Study
FEATURING
Arya Mariam Roy
- 14 views
- December 19, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3
FEATURING
Adam Brufsky
- 168 views
- December 18, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemo in Young Patients With eBC
FEATURING
Megan Tesch
- 40 views
- December 17, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 155 views
- December 17, 2024
- 5
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 105 views
- December 17, 2024
- 4